Condition
Soft Tissue Mass
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05355597Phase 2Terminated
"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"
NCT03667261Not ApplicableCompletedPrimary
Using Sealing Socket Abutment Technique With Immediate Implant in the Mandibular Molars
NCT03452644Completed
US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors
NCT03628170Not ApplicableUnknownPrimary
Soft Tissue Profile Following Socket Preservation With Platelet Rich Fibrin Versus Free Gingival Graft
Showing all 4 trials